BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31243245)

  • 1. Prior History and Incidence of Cancer Impacts on Cardiac Prognosis in Hospitalized Patients With Heart Failure.
    Yoshihisa A; Ichijo Y; Watanabe K; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
    Circ J; 2019 Jul; 83(8):1709-1717. PubMed ID: 31243245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Restless Legs Syndrome on Patients with Heart Failure.
    Yoshihisa A; Misaka T; Kanno Y; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Int Heart J; 2019 Sep; 60(5):1098-1105. PubMed ID: 31484875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.
    Zareini B; Rørth R; Holt A; Mogensen UM; Selmer C; Gislason G; Schou M; Køber L; Torp-Pedersen C; Lamberts M; Kristensen SL
    Cardiovasc Diabetol; 2019 Jun; 18(1):79. PubMed ID: 31189473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
    Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
    BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation.
    Kunimoto M; Yokoyama M; Shimada K; Matsubara T; Aikawa T; Ouchi S; Fukao K; Miyazaki T; Fujiwara K; Abulimiti A; Honzawa A; Shimada A; Yamamoto T; Amano A; Saitoh M; Morisawa T; Takahashi T; Daida H; Minamino T
    Cardiovasc Diabetol; 2021 Oct; 20(1):208. PubMed ID: 34656131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on mortality among older persons with advanced heart failure.
    Ahluwalia SC; Gross CP; Chaudhry SI; Ning YM; Leo-Summers L; Van Ness PH; Fried TR
    J Gen Intern Med; 2012 May; 27(5):513-9. PubMed ID: 22095572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    Okano T; Motoki H; Minamisawa M; Kimura K; Kanai M; Yoshie K; Higuchi S; Saigusa T; Ebisawa S; Okada A; Shoda M; Kuwahara K
    PLoS One; 2020; 15(10):e0241003. PubMed ID: 33095810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    Int Heart J; 2019 Jul; 60(4):876-885. PubMed ID: 31257340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Clinical Significance of 30-Day and 90-Day Rehospitalization for Heart Failure Among Patients With Acute Decompensated Heart Failure in Japan - From the NARA-HF Study.
    Ishihara S; Kawakami R; Nogi M; Hirai K; Hashimoto Y; Nakada Y; Nakagawa H; Ueda T; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Saito Y
    Circ J; 2020 Jan; 84(2):194-202. PubMed ID: 31875584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
    Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2019 Sep; 290():106-112. PubMed ID: 31104823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.